Document Detail


Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response.
MedLine Citation:
PMID:  22127699     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Previous studies of the HLA-B27-transgenic rat model of ankylosing spondylitis (AS) suggested that macrophages develop an intracellular stress response called the unfolded protein response (UPR) and, as a result, secrete increased amounts of cytokines in response to Toll-like receptor agonists such as lipopolysaccharide (LPS). Our objective was to determine whether macrophages from AS patients also undergo a UPR and secrete increased cytokines/chemokines in response to LPS.
METHODS: Peripheral blood monocytes isolated from 10 AS patients and 10 healthy controls were differentiated in vitro with macrophage colony-stimulating factor. Select samples were treated with interferon-γ (IFNγ) to up-regulate class I major histocompatibility complex (HLA-B) expression prior to stimulation with LPS for either 3 hours (for RNA) or 8-24 hours (for supernatant). UPR induction was assessed by measuring the expression of messenger RNA for ERdj4, BiP, and CCAAT/enhancer binding protein homologous protein 10 (CHOP).
RESULTS: Although IFNγ treatment up-regulated HLA-B expression (2-fold; P < 0.0001), neither IFNγ nor LPS substantially enhanced BiP or CHOP expression (<1.3-fold). ERdj4 expression increased weakly, but not significantly, in AS samples treated with IFNγ plus LPS (2.2-fold; P = 0.31). In response to LPS, AS macrophages secreted more CXCL9, interleukin-10 (IL-10), IL-12p70, IL-23, and tumor necrosis factor α than did control macrophages (P ≤ 0.025). The most striking difference was observed for IL-23 (median 265 pg/ml in AS patients versus 9 pg/ml in controls; P = 0.0007). We did not detect significant differences in IL-6, IL-8, or IFNβ production.
CONCLUSION: The greater production of IL-23 by AS patient macrophages in response to LPS provides further support for the development of Th17/IL-23-directed therapy. Since significant UPR induction was not detected in AS patient macrophages, the relationship between UPR and inflammatory cytokine production remains unclear.
Authors:
Ling Zeng; Mary J Lindstrom; Judith A Smith
Related Documents :
9628459 - Diminished monocytic hla-dr expression and ex vivo cytokine secretion capacity in patie...
16511979 - In vitro models for studying human uterine and placental macrophages.
17250589 - Expression of gm1, a marker of lipid rafts, defines two subsets of human monocytes with...
11720009 - Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.
1960409 - Measurement of cytokine production by the monocytic cell line mono mac 6 using novel im...
7659959 - Disturbance of macrophage and monocyte function in the dog by a thromboxane receptor an...
18023589 - Th17 t cells: linking innate and adaptive immunity.
18406209 - New insight into the role of dendritic cells in malaria immune pathogenesis.
9628459 - Diminished monocytic hla-dr expression and ex vivo cytokine secretion capacity in patie...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  63     ISSN:  1529-0131     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-30     Completed Date:  2012-01-27     Revised Date:  2012-04-25    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3807-17     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 by the American College of Rheumatology.
Affiliation:
University of Wisconsin Madison, School of Medicine and Public Health, Madison, WI 53792-4108, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
CCAAT-Enhancer-Binding Proteins / metabolism
Case-Control Studies
Cells, Cultured
Chemokines / metabolism
Cytokines / metabolism
Female
HLA-B Antigens / metabolism
Humans
Interferon-gamma / pharmacology
Interleukin-23 / metabolism*
Lipopolysaccharides / pharmacology*
Macrophages / drug effects*,  metabolism*,  pathology
Male
Middle Aged
Oligopeptides / metabolism
Spondylitis, Ankylosing / metabolism*,  pathology
Transcription Factor CHOP / metabolism
Unfolded Protein Response / drug effects*,  physiology
Young Adult
Grant Support
ID/Acronym/Agency:
1UL1RR02501/RR/NCRR NIH HHS; 1UL1RR025011/RR/NCRR NIH HHS; AI081045/AI/NIAID NIH HHS; K08 AI081045-01/AI/NIAID NIH HHS; K08 AI081045-02/AI/NIAID NIH HHS; K08 AI081045-03/AI/NIAID NIH HHS; UL1 RR025011-01/RR/NCRR NIH HHS; UL1 RR025011-02/RR/NCRR NIH HHS; UL1 RR025011-03/RR/NCRR NIH HHS; UL1 RR025011-04/RR/NCRR NIH HHS; UL1 RR025011-05/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Bax-inhibiting peptide, BIP; 0/CCAAT-Enhancer-Binding Proteins; 0/Chemokines; 0/Cytokines; 0/DDIT3 protein, human; 0/HLA-B Antigens; 0/Interleukin-23; 0/Lipopolysaccharides; 0/Oligopeptides; 147336-12-7/Transcription Factor CHOP; 82115-62-6/Interferon-gamma
Comments/Corrections
Comment In:
Arthritis Rheum. 2011 Dec;63(12):3668-71   [PMID:  22127689 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis indepe...
Next Document:  Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix met...